How FDA Reads an Ad
This article was originally published in RPM Report
Executive Summary
Sponsors wondering what kind of feedback FDA will give on proposed TV ads can turn to the public record: enforcement letters issued by the agency. Here is the most recent example of FDA's objections to a commercial, in the agency's own words.
You may also be interested in...
The New Era in DTC: FDA Plans New Fees, Fines-and Creative Advice
The new FDA law marks a turning point in the relatively short history of direct-to-consumer broadcast ads. Sponsors have preserved the right to advertise, but will have to get used to following FDA's schedule-and taking FDA's advice.
US FDA Alzheimer Guidance Update Reflects Changes In Biomarkers – And Leadership
Latest update to draft guidance on early Alzheimer’s drug development is the third iteration of a document first published in 2013. The history of the guidance is a reflection of structural and leadership changes in the neurology review team at FDA.